Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Reisine

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|January 25, 2011
Drug discovery and the human kinome: recent trendsRichard Eglen, Terry Reisine
Assay and Drug Development Technologies|December 29, 2010
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screeningRichard Eglen, Terry Reisine
SLAS Technology|February 26, 2019
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease ModelingRichard M Eglen, Terry Reisine
Expert Opinion on Drug Discovery|July 25, 2012
Human kinome drug discovery and the emerging importance of atypical allosteric inhibitorsRichard M Eglen, Terry Reisine
Assay and Drug Development Technologies|November 28, 2008
Photoproteins: important new tools in drug discoveryRichard M Eglen, Terry Reisine
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
New insights into GPCR function: implications for HTSRichard M Eglen, Terry Reisine
Journal of Biomolecular Screening|October 18, 2011
Screening for compounds that modulate epigenetic regulation of the transcriptome: an overviewRichard M Eglen, Terry Reisine
Assay and Drug Development Technologies|April 23, 2009
The current status of drug discovery against the human kinomeRichard M Eglen, Terry Reisine
SLAS Technology|October 5, 2018
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead OptimizationRichard M Eglen, Terry Reisine
Faculty Reviews|November 8, 2021
Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansionJulia Kaye, Terry Reisine, Steve Finkbeiner
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|January 25, 2011
Drug discovery and the human kinome: recent trendsRichard Eglen, Terry Reisine
Assay and Drug Development Technologies|December 29, 2010
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screeningRichard Eglen, Terry Reisine
SLAS Technology|February 26, 2019
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease ModelingRichard M Eglen, Terry Reisine
Expert Opinion on Drug Discovery|July 25, 2012
Human kinome drug discovery and the emerging importance of atypical allosteric inhibitorsRichard M Eglen, Terry Reisine
Assay and Drug Development Technologies|November 28, 2008
Photoproteins: important new tools in drug discoveryRichard M Eglen, Terry Reisine
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
New insights into GPCR function: implications for HTSRichard M Eglen, Terry Reisine
Journal of Biomolecular Screening|October 18, 2011
Screening for compounds that modulate epigenetic regulation of the transcriptome: an overviewRichard M Eglen, Terry Reisine
Assay and Drug Development Technologies|April 23, 2009
The current status of drug discovery against the human kinomeRichard M Eglen, Terry Reisine
SLAS Technology|October 5, 2018
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead OptimizationRichard M Eglen, Terry Reisine
Faculty Reviews|November 8, 2021
Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansionJulia Kaye, Terry Reisine, Steve Finkbeiner
Pageof 2